跳至主要内容
临床试验/CTRI/2025/10/096201
CTRI/2025/10/096201尚未招募不适用

Innovative Device for Pressure Point Identification and Vibration Perception Assessment in Diabetic Patients

D.Purushothaman1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
The study is expected to enhance diabetic foot

研究概览

简要总结

A novel device has been developed to improve care for

diabetic patients by identifying pressure points and monitoring

nerve function, aimed at preventing foot ulcers. The device

uses a footscan pressure mat with multiple sensors and

vibrators to assess plantar pressure and vibration perception

threshold. The mat produces a color map and pressure curves

for different foot regions, while the vibratory stimulus helps

measure nerve function. This technology significantly reduces

the risk of diabetic foot ulcers and neuropathy by addressing

high-pressure areas and monitoring nerve health.

Claims of the Invention

• A PORTABLE PRESSURE SENSING AND

VIBRATION PERCEPTION DEVICE FOR EARLY

DETECTION OF PERIPHERAL NEUROPATHY

IN DIABETES THROUGH WHICH WE CAN

IMPLEMENT EFFECTIVE

FOOTWEAR/OFFLOADING DEVICES.

• EASY ACCESIBLE,COST EFFECIENT,TIME

CONSUMING WITH ACCURATE READING

S.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 18 years or older.
  • Diagnosed with Type 1 or Type 2 diabetes mellitus.
  • Participants with or without peripheral neuropathy.

排除标准

  • History of foot or leg surgery within the last 6 months.
  • Presence of active infections or ulcers on feet.
  • Pregnant or planning to become pregnant during the study period.
  • Any severe cardiovascular, neurological, or orthopedic conditions that could affect the ability to participate.

结局指标

主要结局

The study is expected to enhance diabetic foot

时间窗: At baseline, at 4 weeks, and at 8 weeks after initial assessment.

care by accurately identifying pressure points and

时间窗: At baseline, at 4 weeks, and at 8 weeks after initial assessment.

assessing vibration perception, leading to timely

时间窗: At baseline, at 4 weeks, and at 8 weeks after initial assessment.

interventions and improved patient outcomes. Additionally, it aims to empower patients and provide

时间窗: At baseline, at 4 weeks, and at 8 weeks after initial assessment.

valuable insights for healthcare providers in managing

时间窗: At baseline, at 4 weeks, and at 8 weeks after initial assessment.

diabetic complications.

时间窗: At baseline, at 4 weeks, and at 8 weeks after initial assessment.

次要结局

  • Reliability of the innovative device(Day 0 (15–30 min & within 2 h); Day 7 ±2 days.)
  • Usability of the device(Immediately after assessment on Day 0.)
  • Patient comfort during device assessment(Immediately after assessment on Day 0; optional safety/comfort check at 24 h ±6 h by phone.)
  • Predictive ulcer risk(Month 3 ±2 weeks; Month 6 ±3 weeks; Month 12 ±4 weeks.)

研究者

发起方
D.Purushothaman
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Purushothaman D

Saveetha Institute of Medical and Technical Sciences

研究点 (1)

Loading locations...

相似试验